An Upmove May Be Imminent with Alnylam Pharmaceuticals (NASDAQ: ALNY)
Our target potential upside is 4% to 23% in the next 4-6 months.
Read MoreAuthor: Tara Young, Trades Of The Day
The Bulls Are in Control of Aldeyra Therapeutics (NASDAQ: ALDX)
Posted by Tara Young, Trades Of The Day | Jan 11, 2021
Our target potential upside is almost 33% to 120% in the next 3-6 months.
Read MoreInternational Flavors & Fragrances (NYSE: IFF) Broke Out and Looks Ready For a Surge
Posted by Tara Young, Trades Of The Day | Jan 8, 2021
Our target potential upside is 6% to 12% in the next 4 to 6 months.
Read MoreSmith & Wesson Brands (NASDAQ: SWBI) Just Broke Out
Posted by Tara Young, Trades Of The Day | Jan 7, 2021
Our target potential upside is 15% to 44% in the next 4-6 months.
Read MoreBed Bath & Beyond (NASDAQ: BBBY) Broke Out and Looks Ready for a Short-Term Price Surge
Posted by Tara Young, Trades Of The Day | Jan 6, 2021
Our target potential upside is nearly 17% to 41% in the next 3-6 months.
Read More